期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

wHo2014年版《耐药结核病规划管理指南伙伴手册》解读之五（耐药结核病实验室检测） 被引量：8

下载PDF
导出
摘要 结核病实验室检测是确诊结核病，尤其是耐药结核病的重要依据，标准化操作是保证实验室质量的重要前提。耐药结核病的确诊需要检测到结核分枝杆菌（Mycobacterium tuberculosis，Mtb）并且进行药物敏感性试验（drug susceptibility testing，DsT），通过培养分离细菌菌株鉴定种属，采用液体或固体培养进行DST，
作者 王伟 刘京铭 李传友
机构地区 首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所耐药结核病研究北京市重点实验室细菌免疫学研究室
出处 《中国防痨杂志》 CAS 2015年第6期655-658,共4页 Chinese Journal of Antituberculosis
基金 北京市医院管理局临床医学发展专项经费资助（ZYLX201304）
关键词 耐药结核病 实验室检测 管理指南 TUBERCULOSIS 药物敏感性试验 解读 手册 结核分枝杆菌
分类号 R52 [医药卫生—内科学]
  • 相关文献

参考文献9

  • 1World Health Organization. Policy framework for implemen- ting new tuberculosis diagnostics. WHO/HTM/TB/2010.07. Geneva:World Health Organization, 2010.
  • 2World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-re- sistant tuberculosis. WHO/HTM/TB/2014. 11. Geneva:World Health Organization, 2014.
  • 3World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis-Emergency update 2008. WHO/HTM/TB/2008. 402. Geneva:World Health Or- ganization, 2010.
  • 4World Health Organization. A roadmap for ensuring quality tuberculosis diagnostics services within national laboratorystrategic plans. WHO/HTM/TB/2010. Geneva: World Health Organization, 2010.
  • 5张洁,邢青,王甦民,易俊莉,杨新宇,丁北川,苏建荣.传统培养法与PCR-荧光探针法鉴定分枝杆菌的对比研究[J].中国防痨杂志,2015,37(3):291-294. 被引量：17
  • 6王桂荣,付育红,梁倩,尚媛媛,姜广路,赵立平,于霞,陈素婷,黄海荣.应用多重PCR方法快速鉴定结核分枝杆菌复合群与非结核分枝杆菌的研究[J].中国防痨杂志,2013,35(9):686-689. 被引量：14
  • 7World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF as- say for the diagnosis of pulmonary and extrapu[monary TB in adults and children: policy update. WHO/HTM/TB/2011.4.Geneva:World Health Organization, 2011.
  • 8World Health Organization. Rapid implementation of the XpertMTB/RIF diagnostic test. WHO/HTM/TB/2011. Ge- neva:World Health Organization, 2011.
  • 9World Health Organization. Policy guidance on drug-suscepti- bility testing (DST) of second-line antituberculosis drugs. WHO/HTM/TB/2008. Geneva.. World Health Organization, 2008.

二级参考文献20

  • 1中国防痨协会基础专业委员会.结核病诊断实验室检验规程.北京:中国教育出版社,2006,46-51.
  • 2Katoch VM. Infections due to non-tuberculous mycobacteria (NTM). Indian J Med Res, 2004, 120(4) :290-304.
  • 3Frieden TR, Sterling TR, Munsiff SS, et al. Tuberculosis. Lancet, 2003, 362(9387):887-899.
  • 4Mokaddas E, Ahmad S. Development and evaluation of a mul- tiplex PCR for rapid detection and differentiation of Mycobacte- riurn tuberculosis complex members from non-tuberculous my- cobacteria. Jpn J Infect Dis, 2007, 60(2/3) : 140-144.
  • 5Kirschner P, Bottger EC. Species identification of mycobacteria using rDNA sequencing. Methods Mol Biol, 1998, 101. 349-361.
  • 6Lee H, Bang HE, Bai GH, et al. Novel polymorphic region of the rpoB gene containing Mycobacterium species-specific se- quences and its use in identification of mycobacteria. J Clin Microbiol, 2003, 41(5) :2213-2218.
  • 7Roth A, Fischer M, Hamid ME, et al. Differentiation of phy- logenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J Clin Microbiol, 1998, 36(1) : 139-147.
  • 8Liebana E, Aranaz A, Francis B, et al. Assessment of genetic markers for species differentiation within the Mycobacterium tuberculosis complex. J Clin Microhiol, 1996, 34(4) :933-938.
  • 9Kent L, McHugh TD, Billington O, et al. Demonstration of homology between IS6110 of Myeobacterium tuberculosis and DNAs of other Mycobacterium spp. J Clin Mierobiol, 1995, 33 (9) :2290-2293.
  • 10Magdalena J, Vach6e A, Supply P, et al. Identification of a new DNA region specific for members of Mycobacterium tuber- culosis complex. J Clin Microbiol, 1998, 36(4) : 937-943.

共引文献28

同被引文献61

  • 1韦琪平.耐多药结核病研究进展[J].医学信息（医学与计算机应用）,2014,0(22):670-670. 被引量：3
  • 2谷金莲,祁自柏,扬振,于洋,张华远,李河民.第5套丙型肝炎病毒抗体诊断试剂国家参考品的研制[J].中国生物制品学杂志,2006,19(1):68-70. 被引量：20
  • 3World Health Organization. Global tuberculosis report 2014. WHO/HTM/TB/2014.08. Geneva: World Health Organiza- tion, 2014.
  • 4World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection ot7 tuberculosis and rifampicin resistance: Xpert MTB/RIF as- say for the diagnosis of pulmonary and extrapulmonary TB in adults and children: Policy update. WHO/HTM/TB/ 2013.16. Geneva:World Health Organization, 2013.
  • 5World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug- resistant tuberculosis. WHO/HTM/TB/2014.11. Geneva: Wcrld Health Organization. 2014.
  • 6Clinical and Laboratory Standards Institute. EP12-A2, User Protocol {or Evaluation of Qualitative Test Performance Approved Guideline-Second Edition [S]. USA: Clinical and Laboratory Standards Institute,2008.
  • 7Clinical and Laboratory Standards Institute. EP15-A2, User Verification of Performance for Precision and True- ness Approved Guideline-Second Edition[S]. USA : Clin- ical and Laboratory Standards Institute, 2005.
  • 8徐伟文.体外诊断试剂研制常用技术指标之分析性能评估[J].分子诊断与治疗杂志,2010,2(2):140-144. 被引量：35
  • 9肖和平.中国耐药结核病的流行现状与治疗对策[J].中华结核和呼吸杂志,2010,33(7):481-482. 被引量：44
  • 10张明,娄培安,刘林,陈培培,张亚,刘杰,李军政.耐多药肺结核患者耐药情况及影响因素[J].中国公共卫生,2010,26(11):1439-1440. 被引量：18

引证文献8

二级引证文献36

中国防痨杂志
2015年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部